By Scott Gottlieb (Original source Washington Post)
“Cannabidiol — better known as CBD — is everywhere, from small specialty shops to large national retail chains. It can be found in foods, supplements, drugs, oils, creams, pet foods and more, and sellers purport that the compound treats everything from cancer to depression. Analysts say the market could surpass $20 billion by 2024.
But many of the compound’s expansive benefits are fanciful, and in fact, the sale of much of the product is illegal under current law. The Food and Drug Administration must act to make sure commercial interests don’t strip away any legitimate value that the compound might have.
Much CBD is derived from hemp, the commodity that was legalized in the 2018 farm bill. But the law still prohibits putting the chemical in food or pet food, and the FDA has issued repeated warnings and actions on the blooming CBD industry. In fact, there’s only one legally available purified form of CBD: the drug Epidiolex, approved by the FDA in 2018 to treat seizure disorders.”
Click here to see more
Dr. Sanjay Gupta: Why You Should Brush Your Teeth Before Breakfast
We all know we should brush and floss our teeth. But the reason goes beyond a sparkling smile and keeping bad breath at bay. The mouth is a critical and often overlooked organ when it comes to improving overall health. Dr. Sanjay Gupta sits down…
Thought Leader: Sanjay Gupta
Erika Ayers Badan: You Are The Problem (And The Solution)
This is an episode for people grappling with how to manage and how to embrace AI. Good managers in the future will seamlessly balance being…
Thought Leader: Erika Ayers Badan
Peter Zeihan: Canada’s China Option
Canada’s prime minister, Mark Carney, recently visited Beijing. This trip sparked rumors that Canada was ditching the US and buddying up with China instead. Let’s…
Thought Leader: Peter Zeihan
Dr. Scott Gottlieb on Finding Cures for Rare Diseases
Thought Leader: Scott Gottlieb
Dr. Scott Gottlieb: What’s Next for Childhood Vaccines
Thought Leader: Scott Gottlieb
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb
